Pharma & Healthcare
Global Liposome Drug Delivery Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 301002
- Pages: 147
- Figures: 150
- Views: 28
In 2024, the global market size of Liposome Drug Delivery was estimated to be worth US$ 4742 million and is forecast to reach approximately US$ 10890 million by 2031 with a CAGR of 12.8% during the forecast period 2025-2031.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
Global Liposome Drug Delivery key players include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. Global top five manufacturers hold a share about 60%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both with a share about 30 percent. In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer & Tumor Therapy, followed by Fungal Infection Therapy, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liposome Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposome Drug Delivery.
The Liposome Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Vial) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposome Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposome Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segment by Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Liposome Drug Delivery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposome Drug Delivery sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
Global Liposome Drug Delivery key players include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. Global top five manufacturers hold a share about 60%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both with a share about 30 percent. In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer & Tumor Therapy, followed by Fungal Infection Therapy, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liposome Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposome Drug Delivery.
The Liposome Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Vial) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposome Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposome Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segment by Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Liposome Drug Delivery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposome Drug Delivery sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Liposome Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Liposome Drug Delivery Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposome Drug Delivery Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liposome Drug Delivery Market Size Estimates and Forecasts
2.1.1 Global Liposome Drug Delivery Revenue 2020-2031
2.1.2 Global Liposome Drug Delivery Sales 2020-2031
2.2 Liposome Drug Delivery Market Size by Region: 2024 Versus 2031
2.3 Liposome Drug Delivery Sales by Region (2020-2031)
2.3.1 Global Liposome Drug Delivery Sales by Region: 2020-2025
2.3.2 Global Liposome Drug Delivery Sales Forecast by Region (2026-2031)
2.3.3 Global Liposome Drug Delivery Sales Market Share by Region (2020-2031)
2.4 Liposome Drug Delivery Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Liposome Drug Delivery Revenue by Region: 2020-2025
2.4.2 Global Liposome Drug Delivery Revenue Forecast by Region (2026-2031)
2.4.3 Global Liposome Drug Delivery Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Liposome Drug Delivery Sales by Type (2020-2031)
3.1.1.1 Global Liposome Drug Delivery Sales Volume by Type (2020-2031)
3.1.1.2 Global Liposome Drug Delivery Sales Market Share by Type (2020-2031)
3.1.2 Global Liposome Drug Delivery Revenue by Type (2020-2031)
3.1.2.1 Global Liposome Drug Delivery Revenue by Type (2020-2031)
3.1.2.2 Global Liposome Drug Delivery Revenue Market Share by Type (2020-2031)
3.1.3 Liposome Drug Delivery Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Liposome Drug Delivery Sales by Application (2020-2031)
3.2.1.1 Global Liposome Drug Delivery Sales Volume by Application (2020-2031)
3.2.1.2 Global Liposome Drug Delivery Sales Market Share by Application (2020-2031)
3.2.2 Global Liposome Drug Delivery Revenue by Application (2020-2031)
3.2.2.1 Global Liposome Drug Delivery Revenue by Application (2020-2031)
3.2.2.2 Global Liposome Drug Delivery Revenue Market Share by Application (2020-2031)
3.2.3 Liposome Drug Delivery Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Liposomal Doxorubicin of Liposome Drug Delivery Revenue Market Share by Application
3.3.2 Liposomal Amphoteracin B of Liposome Drug Delivery Revenue Market Share by Application
3.3.3 Liposomal Paclitaxel of Liposome Drug Delivery Revenue Market Share by Application
3.3.4 Others of Liposome Drug Delivery Revenue Market Share by Application
4 Global Liposome Drug Delivery by Manufacturers
4.1 Global Top Liposome Drug Delivery Manufacturers by Sales (2020-2025)
4.1.1 Global Liposome Drug Delivery Sales by Manufacturer (2020-2025)
4.1.2 Global Liposome Drug Delivery Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Liposome Drug Delivery Manufacturers by Revenue (2020-2025)
4.2.1 Global Liposome Drug Delivery Revenue by Manufacturer (2020-2025)
4.2.2 Global Liposome Drug Delivery Revenue Share by Manufacturer (2020-2025)
4.3 Global Liposome Drug Delivery Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Liposome Drug Delivery Manufacturers Covered: Ranking by Revenue
4.4.2 Global Liposome Drug Delivery Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Liposome Drug Delivery Manufacturing Base Distribution, Product Type
4.5.1 Liposome Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Liposome Drug Delivery Market
4.5.3 Manufacturers Liposome Drug Delivery Product Type and Application
4.5.4 Liposomal Doxorubicin Market Sales of Liposome Drug Delivery by Manufacturer
4.5.5 Liposomal Amphoteracin B Market Sales of Liposome Drug Delivery by Manufacturer
4.5.6 Liposomal Paclitaxel Market Sales of Liposome Drug Delivery by Manufacturer
4.5.7 Others Market Sales of Liposome Drug Delivery by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Gilead Sciences
5.1.1 Gilead Sciences Company Information
5.1.2 Gilead Sciences Description, Business Overview
5.1.3 Gilead Sciences Liposome Drug Delivery Products Offered
5.1.4 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Gilead Sciences Liposome Drug Delivery Sales by Product in 2024
5.1.6 Gilead Sciences Liposome Drug Delivery Sales by Application in 2024
5.1.7 Gilead Sciences Liposome Drug Delivery Sales by Geographic Area in 2024
5.1.8 Gilead Sciences Recent Developments
5.2 Pacira
5.2.1 Pacira Company Information
5.2.2 Pacira Description, Business Overview
5.2.3 Pacira Liposome Drug Delivery Products Offered
5.2.4 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Pacira Liposome Drug Delivery Sales by Product in 2024
5.2.6 Pacira Liposome Drug Delivery Sales by Application in 2024
5.2.7 Pacira Liposome Drug Delivery Sales by Geographic Area in 2024
5.2.8 Pacira Recent Developments
5.3 Sun Pharmaceutical
5.3.1 Sun Pharmaceutical Company Information
5.3.2 Sun Pharmaceutical Description, Business Overview
5.3.3 Sun Pharmaceutical Liposome Drug Delivery Products Offered
5.3.4 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Sun Pharmaceutical Liposome Drug Delivery Sales by Product in 2024
5.3.6 Sun Pharmaceutical Liposome Drug Delivery Sales by Application in 2024
5.3.7 Sun Pharmaceutical Liposome Drug Delivery Sales by Geographic Area in 2024
5.3.8 Sun Pharmaceutical Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Company Information
5.4.2 Johnson & Johnson Description, Business Overview
5.4.3 Johnson & Johnson Liposome Drug Delivery Products Offered
5.4.4 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Johnson & Johnson Liposome Drug Delivery Sales by Product in 2024
5.4.6 Johnson & Johnson Liposome Drug Delivery Sales by Application in 2024
5.4.7 Johnson & Johnson Liposome Drug Delivery Sales by Geographic Area in 2024
5.4.8 Johnson & Johnson Recent Developments
5.5 Luye Pharma
5.5.1 Luye Pharma Company Information
5.5.2 Luye Pharma Description, Business Overview
5.5.3 Luye Pharma Liposome Drug Delivery Products Offered
5.5.4 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Luye Pharma Liposome Drug Delivery Sales by Product in 2024
5.5.6 Luye Pharma Liposome Drug Delivery Sales by Application in 2024
5.5.7 Luye Pharma Liposome Drug Delivery Sales by Geographic Area in 2024
5.5.8 Luye Pharma Recent Developments
5.6 Sigma-Tau
5.6.1 Sigma-Tau Company Information
5.6.2 Sigma-Tau Description, Business Overview
5.6.3 Sigma-Tau Liposome Drug Delivery Products Offered
5.6.4 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Sigma-Tau Liposome Drug Delivery Sales by Product in 2024
5.6.6 Sigma-Tau Liposome Drug Delivery Sales by Application in 2024
5.6.7 Sigma-Tau Liposome Drug Delivery Sales by Geographic Area in 2024
5.6.8 Sigma-Tau Recent Developments
5.7 Ipsen (Onivyde)
5.7.1 Ipsen (Onivyde) Company Information
5.7.2 Ipsen (Onivyde) Description, Business Overview
5.7.3 Ipsen (Onivyde) Liposome Drug Delivery Products Offered
5.7.4 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Ipsen (Onivyde) Liposome Drug Delivery Sales by Product in 2024
5.7.6 Ipsen (Onivyde) Liposome Drug Delivery Sales by Application in 2024
5.7.7 Ipsen (Onivyde) Liposome Drug Delivery Sales by Geographic Area in 2024
5.7.8 Ipsen (Onivyde) Recent Developments
5.8 CSPC
5.8.1 CSPC Company Information
5.8.2 CSPC Description, Business Overview
5.8.3 CSPC Liposome Drug Delivery Products Offered
5.8.4 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.8.5 CSPC Liposome Drug Delivery Sales by Product in 2024
5.8.6 CSPC Liposome Drug Delivery Sales by Application in 2024
5.8.7 CSPC Liposome Drug Delivery Sales by Geographic Area in 2024
5.8.8 CSPC Recent Developments
5.9 Teva Pharmaceutical
5.9.1 Teva Pharmaceutical Company Information
5.9.2 Teva Pharmaceutical Description, Business Overview
5.9.3 Teva Pharmaceutical Liposome Drug Delivery Products Offered
5.9.4 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Teva Pharmaceutical Liposome Drug Delivery Sales by Product in 2024
5.9.6 Teva Pharmaceutical Liposome Drug Delivery Sales by Application in 2024
5.9.7 Teva Pharmaceutical Liposome Drug Delivery Sales by Geographic Area in 2024
5.9.8 Teva Pharmaceutical Recent Developments
5.10 Novartis
5.10.1 Novartis Company Information
5.10.2 Novartis Description, Business Overview
5.10.3 Novartis Liposome Drug Delivery Products Offered
5.10.4 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Novartis Liposome Drug Delivery Sales by Product in 2024
5.10.6 Novartis Liposome Drug Delivery Sales by Application in 2024
5.10.7 Novartis Liposome Drug Delivery Sales by Geographic Area in 2024
5.10.8 Novartis Recent Developments
5.11 Fudan-Zhangjiang
5.11.1 Fudan-Zhangjiang Company Information
5.11.2 Fudan-Zhangjiang Description, Business Overview
5.11.3 Fudan-Zhangjiang Liposome Drug Delivery Products Offered
5.11.4 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Fudan-Zhangjiang Liposome Drug Delivery Sales by Product in 2024
5.11.6 Fudan-Zhangjiang Liposome Drug Delivery Sales by Application in 2024
5.11.7 Fudan-Zhangjiang Liposome Drug Delivery Sales by Geographic Area in 2024
5.11.8 Fudan-Zhangjiang Recent Developments
6 North America
6.1 North America Liposome Drug Delivery Market Size YoY Growth 2020-2031
6.2 North America Liposome Drug Delivery Market Facts & Figures by Country
6.2.1 North America Liposome Drug Delivery Sales by Country (2020-2031)
6.2.2 North America Liposome Drug Delivery Revenue by Country (2020-2031)
6.3 North America Liposome Drug Delivery Sales by Type (2020-2025)
6.4 North America Liposome Drug Delivery Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Liposome Drug Delivery Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Liposome Drug Delivery Market Facts & Figures by Region
7.2.1 Asia-Pacific Liposome Drug Delivery Sales by Region (2020-2031)
7.2.2 Asia-Pacific Liposome Drug Delivery Revenue by Region (2020-2031)
7.3 Asia-Pacific Liposome Drug Delivery Sales by Type (2020-2025)
7.4 Asia-Pacific Liposome Drug Delivery Sales by Application (2020-2025)
8 Europe
8.1 Europe Liposome Drug Delivery Market Size YoY Growth 2020-2031
8.2 Europe Liposome Drug Delivery Market Facts & Figures by Country
8.2.1 Europe Liposome Drug Delivery Sales by Country (2020-2031)
8.2.2 Europe Liposome Drug Delivery Revenue by Country (2020-2031)
8.3 Europe Liposome Drug Delivery Sales by Type (2020-2025)
8.4 Europe Liposome Drug Delivery Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Liposome Drug Delivery Market Size YoY Growth 2020-2031
9.2 Latin America Liposome Drug Delivery Market Facts & Figures by Country
9.2.1 Latin America Liposome Drug Delivery Sales by Country (2020-2031)
9.2.2 Latin America Liposome Drug Delivery Revenue by Country (2020-2031)
9.3 Latin America Liposome Drug Delivery Sales by Type (2020-2025)
9.4 Latin America Liposome Drug Delivery Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Liposome Drug Delivery Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Liposome Drug Delivery Market Facts & Figures by Country
10.2.1 Middle East and Africa Liposome Drug Delivery Sales by Country (2020-2031)
10.2.2 Middle East and Africa Liposome Drug Delivery Revenue by Country (2020-2031)
10.3 Middle East and Africa Liposome Drug Delivery Sales by Type (2020-2025)
10.4 Middle East and Africa Liposome Drug Delivery Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Liposome Drug Delivery Supply Chain Analysis
11.2 Liposome Drug Delivery Key Raw Materials and Upstream Suppliers
11.3 Liposome Drug Delivery Clients Analysis
11.4 Liposome Drug Delivery Sales Channel and Sales Model Analysis
11.4.1 Liposome Drug Delivery Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Liposome Drug Delivery Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Liposome Drug Delivery Distributors
12 Liposome Drug Delivery Market Dynamics
12.1 Liposome Drug Delivery Industry Trends
12.2 Liposome Drug Delivery Market Drivers
12.3 Liposome Drug Delivery Market Challenges
12.4 Liposome Drug Delivery Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Liposome Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Liposome Drug Delivery Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposome Drug Delivery Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liposome Drug Delivery Market Size Estimates and Forecasts
2.1.1 Global Liposome Drug Delivery Revenue 2020-2031
2.1.2 Global Liposome Drug Delivery Sales 2020-2031
2.2 Liposome Drug Delivery Market Size by Region: 2024 Versus 2031
2.3 Liposome Drug Delivery Sales by Region (2020-2031)
2.3.1 Global Liposome Drug Delivery Sales by Region: 2020-2025
2.3.2 Global Liposome Drug Delivery Sales Forecast by Region (2026-2031)
2.3.3 Global Liposome Drug Delivery Sales Market Share by Region (2020-2031)
2.4 Liposome Drug Delivery Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Liposome Drug Delivery Revenue by Region: 2020-2025
2.4.2 Global Liposome Drug Delivery Revenue Forecast by Region (2026-2031)
2.4.3 Global Liposome Drug Delivery Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Liposome Drug Delivery Sales by Type (2020-2031)
3.1.1.1 Global Liposome Drug Delivery Sales Volume by Type (2020-2031)
3.1.1.2 Global Liposome Drug Delivery Sales Market Share by Type (2020-2031)
3.1.2 Global Liposome Drug Delivery Revenue by Type (2020-2031)
3.1.2.1 Global Liposome Drug Delivery Revenue by Type (2020-2031)
3.1.2.2 Global Liposome Drug Delivery Revenue Market Share by Type (2020-2031)
3.1.3 Liposome Drug Delivery Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Liposome Drug Delivery Sales by Application (2020-2031)
3.2.1.1 Global Liposome Drug Delivery Sales Volume by Application (2020-2031)
3.2.1.2 Global Liposome Drug Delivery Sales Market Share by Application (2020-2031)
3.2.2 Global Liposome Drug Delivery Revenue by Application (2020-2031)
3.2.2.1 Global Liposome Drug Delivery Revenue by Application (2020-2031)
3.2.2.2 Global Liposome Drug Delivery Revenue Market Share by Application (2020-2031)
3.2.3 Liposome Drug Delivery Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Liposomal Doxorubicin of Liposome Drug Delivery Revenue Market Share by Application
3.3.2 Liposomal Amphoteracin B of Liposome Drug Delivery Revenue Market Share by Application
3.3.3 Liposomal Paclitaxel of Liposome Drug Delivery Revenue Market Share by Application
3.3.4 Others of Liposome Drug Delivery Revenue Market Share by Application
4 Global Liposome Drug Delivery by Manufacturers
4.1 Global Top Liposome Drug Delivery Manufacturers by Sales (2020-2025)
4.1.1 Global Liposome Drug Delivery Sales by Manufacturer (2020-2025)
4.1.2 Global Liposome Drug Delivery Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Liposome Drug Delivery Manufacturers by Revenue (2020-2025)
4.2.1 Global Liposome Drug Delivery Revenue by Manufacturer (2020-2025)
4.2.2 Global Liposome Drug Delivery Revenue Share by Manufacturer (2020-2025)
4.3 Global Liposome Drug Delivery Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Liposome Drug Delivery Manufacturers Covered: Ranking by Revenue
4.4.2 Global Liposome Drug Delivery Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Liposome Drug Delivery Manufacturing Base Distribution, Product Type
4.5.1 Liposome Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Liposome Drug Delivery Market
4.5.3 Manufacturers Liposome Drug Delivery Product Type and Application
4.5.4 Liposomal Doxorubicin Market Sales of Liposome Drug Delivery by Manufacturer
4.5.5 Liposomal Amphoteracin B Market Sales of Liposome Drug Delivery by Manufacturer
4.5.6 Liposomal Paclitaxel Market Sales of Liposome Drug Delivery by Manufacturer
4.5.7 Others Market Sales of Liposome Drug Delivery by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Gilead Sciences
5.1.1 Gilead Sciences Company Information
5.1.2 Gilead Sciences Description, Business Overview
5.1.3 Gilead Sciences Liposome Drug Delivery Products Offered
5.1.4 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Gilead Sciences Liposome Drug Delivery Sales by Product in 2024
5.1.6 Gilead Sciences Liposome Drug Delivery Sales by Application in 2024
5.1.7 Gilead Sciences Liposome Drug Delivery Sales by Geographic Area in 2024
5.1.8 Gilead Sciences Recent Developments
5.2 Pacira
5.2.1 Pacira Company Information
5.2.2 Pacira Description, Business Overview
5.2.3 Pacira Liposome Drug Delivery Products Offered
5.2.4 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Pacira Liposome Drug Delivery Sales by Product in 2024
5.2.6 Pacira Liposome Drug Delivery Sales by Application in 2024
5.2.7 Pacira Liposome Drug Delivery Sales by Geographic Area in 2024
5.2.8 Pacira Recent Developments
5.3 Sun Pharmaceutical
5.3.1 Sun Pharmaceutical Company Information
5.3.2 Sun Pharmaceutical Description, Business Overview
5.3.3 Sun Pharmaceutical Liposome Drug Delivery Products Offered
5.3.4 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Sun Pharmaceutical Liposome Drug Delivery Sales by Product in 2024
5.3.6 Sun Pharmaceutical Liposome Drug Delivery Sales by Application in 2024
5.3.7 Sun Pharmaceutical Liposome Drug Delivery Sales by Geographic Area in 2024
5.3.8 Sun Pharmaceutical Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Company Information
5.4.2 Johnson & Johnson Description, Business Overview
5.4.3 Johnson & Johnson Liposome Drug Delivery Products Offered
5.4.4 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Johnson & Johnson Liposome Drug Delivery Sales by Product in 2024
5.4.6 Johnson & Johnson Liposome Drug Delivery Sales by Application in 2024
5.4.7 Johnson & Johnson Liposome Drug Delivery Sales by Geographic Area in 2024
5.4.8 Johnson & Johnson Recent Developments
5.5 Luye Pharma
5.5.1 Luye Pharma Company Information
5.5.2 Luye Pharma Description, Business Overview
5.5.3 Luye Pharma Liposome Drug Delivery Products Offered
5.5.4 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Luye Pharma Liposome Drug Delivery Sales by Product in 2024
5.5.6 Luye Pharma Liposome Drug Delivery Sales by Application in 2024
5.5.7 Luye Pharma Liposome Drug Delivery Sales by Geographic Area in 2024
5.5.8 Luye Pharma Recent Developments
5.6 Sigma-Tau
5.6.1 Sigma-Tau Company Information
5.6.2 Sigma-Tau Description, Business Overview
5.6.3 Sigma-Tau Liposome Drug Delivery Products Offered
5.6.4 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Sigma-Tau Liposome Drug Delivery Sales by Product in 2024
5.6.6 Sigma-Tau Liposome Drug Delivery Sales by Application in 2024
5.6.7 Sigma-Tau Liposome Drug Delivery Sales by Geographic Area in 2024
5.6.8 Sigma-Tau Recent Developments
5.7 Ipsen (Onivyde)
5.7.1 Ipsen (Onivyde) Company Information
5.7.2 Ipsen (Onivyde) Description, Business Overview
5.7.3 Ipsen (Onivyde) Liposome Drug Delivery Products Offered
5.7.4 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Ipsen (Onivyde) Liposome Drug Delivery Sales by Product in 2024
5.7.6 Ipsen (Onivyde) Liposome Drug Delivery Sales by Application in 2024
5.7.7 Ipsen (Onivyde) Liposome Drug Delivery Sales by Geographic Area in 2024
5.7.8 Ipsen (Onivyde) Recent Developments
5.8 CSPC
5.8.1 CSPC Company Information
5.8.2 CSPC Description, Business Overview
5.8.3 CSPC Liposome Drug Delivery Products Offered
5.8.4 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.8.5 CSPC Liposome Drug Delivery Sales by Product in 2024
5.8.6 CSPC Liposome Drug Delivery Sales by Application in 2024
5.8.7 CSPC Liposome Drug Delivery Sales by Geographic Area in 2024
5.8.8 CSPC Recent Developments
5.9 Teva Pharmaceutical
5.9.1 Teva Pharmaceutical Company Information
5.9.2 Teva Pharmaceutical Description, Business Overview
5.9.3 Teva Pharmaceutical Liposome Drug Delivery Products Offered
5.9.4 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Teva Pharmaceutical Liposome Drug Delivery Sales by Product in 2024
5.9.6 Teva Pharmaceutical Liposome Drug Delivery Sales by Application in 2024
5.9.7 Teva Pharmaceutical Liposome Drug Delivery Sales by Geographic Area in 2024
5.9.8 Teva Pharmaceutical Recent Developments
5.10 Novartis
5.10.1 Novartis Company Information
5.10.2 Novartis Description, Business Overview
5.10.3 Novartis Liposome Drug Delivery Products Offered
5.10.4 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Novartis Liposome Drug Delivery Sales by Product in 2024
5.10.6 Novartis Liposome Drug Delivery Sales by Application in 2024
5.10.7 Novartis Liposome Drug Delivery Sales by Geographic Area in 2024
5.10.8 Novartis Recent Developments
5.11 Fudan-Zhangjiang
5.11.1 Fudan-Zhangjiang Company Information
5.11.2 Fudan-Zhangjiang Description, Business Overview
5.11.3 Fudan-Zhangjiang Liposome Drug Delivery Products Offered
5.11.4 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Fudan-Zhangjiang Liposome Drug Delivery Sales by Product in 2024
5.11.6 Fudan-Zhangjiang Liposome Drug Delivery Sales by Application in 2024
5.11.7 Fudan-Zhangjiang Liposome Drug Delivery Sales by Geographic Area in 2024
5.11.8 Fudan-Zhangjiang Recent Developments
6 North America
6.1 North America Liposome Drug Delivery Market Size YoY Growth 2020-2031
6.2 North America Liposome Drug Delivery Market Facts & Figures by Country
6.2.1 North America Liposome Drug Delivery Sales by Country (2020-2031)
6.2.2 North America Liposome Drug Delivery Revenue by Country (2020-2031)
6.3 North America Liposome Drug Delivery Sales by Type (2020-2025)
6.4 North America Liposome Drug Delivery Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Liposome Drug Delivery Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Liposome Drug Delivery Market Facts & Figures by Region
7.2.1 Asia-Pacific Liposome Drug Delivery Sales by Region (2020-2031)
7.2.2 Asia-Pacific Liposome Drug Delivery Revenue by Region (2020-2031)
7.3 Asia-Pacific Liposome Drug Delivery Sales by Type (2020-2025)
7.4 Asia-Pacific Liposome Drug Delivery Sales by Application (2020-2025)
8 Europe
8.1 Europe Liposome Drug Delivery Market Size YoY Growth 2020-2031
8.2 Europe Liposome Drug Delivery Market Facts & Figures by Country
8.2.1 Europe Liposome Drug Delivery Sales by Country (2020-2031)
8.2.2 Europe Liposome Drug Delivery Revenue by Country (2020-2031)
8.3 Europe Liposome Drug Delivery Sales by Type (2020-2025)
8.4 Europe Liposome Drug Delivery Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Liposome Drug Delivery Market Size YoY Growth 2020-2031
9.2 Latin America Liposome Drug Delivery Market Facts & Figures by Country
9.2.1 Latin America Liposome Drug Delivery Sales by Country (2020-2031)
9.2.2 Latin America Liposome Drug Delivery Revenue by Country (2020-2031)
9.3 Latin America Liposome Drug Delivery Sales by Type (2020-2025)
9.4 Latin America Liposome Drug Delivery Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Liposome Drug Delivery Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Liposome Drug Delivery Market Facts & Figures by Country
10.2.1 Middle East and Africa Liposome Drug Delivery Sales by Country (2020-2031)
10.2.2 Middle East and Africa Liposome Drug Delivery Revenue by Country (2020-2031)
10.3 Middle East and Africa Liposome Drug Delivery Sales by Type (2020-2025)
10.4 Middle East and Africa Liposome Drug Delivery Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Liposome Drug Delivery Supply Chain Analysis
11.2 Liposome Drug Delivery Key Raw Materials and Upstream Suppliers
11.3 Liposome Drug Delivery Clients Analysis
11.4 Liposome Drug Delivery Sales Channel and Sales Model Analysis
11.4.1 Liposome Drug Delivery Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Liposome Drug Delivery Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Liposome Drug Delivery Distributors
12 Liposome Drug Delivery Market Dynamics
12.1 Liposome Drug Delivery Industry Trends
12.2 Liposome Drug Delivery Market Drivers
12.3 Liposome Drug Delivery Market Challenges
12.4 Liposome Drug Delivery Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Liposome Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Liposome Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Liposome Drug Delivery Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Liposome Drug Delivery Sales by Region (2020-2025) & (K Vial)
Table 5. Global Liposome Drug Delivery Sales Forecast by Region (2026-2031) & (K Vial)
Table 6. Global Liposome Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Liposome Drug Delivery Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Liposome Drug Delivery Sales Volume by Type (2020-2025) & (K Vial)
Table 9. Global Liposome Drug Delivery Sales Volume by Type (2026-2031) & (K Vial)
Table 10. Global Liposome Drug Delivery Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Liposome Drug Delivery Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Liposome Drug Delivery Sales Volume by Application (2020-2025) & (K Vial)
Table 13. Global Liposome Drug Delivery Sales Volume by Application (2026-2031) & (K Vial)
Table 14. Global Liposome Drug Delivery Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Liposome Drug Delivery Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Liposome Drug Delivery Sales by Manufacturer (2020-2025) & (K Vial)
Table 17. Global Liposome Drug Delivery Sales Share by Manufacturer (2020-2025)
Table 18. Liposome Drug Delivery Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Liposome Drug Delivery Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Liposome Drug Delivery Price (2020-2025) & (USD/Vial)
Table 21. Ranking of Global Top Liposome Drug Delivery Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Liposome Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Liposome Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Drug Delivery as of 2024)
Table 24. Liposome Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Liposome Drug Delivery Market
Table 26. Manufacturers Liposome Drug Delivery Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Gilead Sciences Company Information
Table 29. Gilead Sciences Description and Business Overview
Table 30. Gilead Sciences Liposome Drug Delivery Product
Table 31. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 32. Gilead Sciences Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 33. Gilead Sciences Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 34. Gilead Sciences Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 35. Gilead Sciences Recent Developments
Table 36. Pacira Company Information
Table 37. Pacira Description and Business Overview
Table 38. Pacira Liposome Drug Delivery Product
Table 39. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 40. Pacira Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 41. Pacira Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 42. Pacira Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 43. Pacira Recent Developments
Table 44. Sun Pharmaceutical Company Information
Table 45. Sun Pharmaceutical Description and Business Overview
Table 46. Sun Pharmaceutical Liposome Drug Delivery Product
Table 47. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 48. Sun Pharmaceutical Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 49. Sun Pharmaceutical Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 50. Sun Pharmaceutical Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 51. Sun Pharmaceutical Recent Developments
Table 52. Johnson & Johnson Company Information
Table 53. Johnson & Johnson Description and Business Overview
Table 54. Johnson & Johnson Liposome Drug Delivery Product
Table 55. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 56. Johnson & Johnson Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 57. Johnson & Johnson Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 58. Johnson & Johnson Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 59. Johnson & Johnson Recent Developments
Table 60. Luye Pharma Company Information
Table 61. Luye Pharma Description and Business Overview
Table 62. Luye Pharma Liposome Drug Delivery Product
Table 63. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 64. Luye Pharma Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 65. Luye Pharma Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 66. Luye Pharma Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 67. Luye Pharma Recent Developments
Table 68. Sigma-Tau Company Information
Table 69. Sigma-Tau Description and Business Overview
Table 70. Sigma-Tau Liposome Drug Delivery Product
Table 71. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 72. Sigma-Tau Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 73. Sigma-Tau Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 74. Sigma-Tau Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 75. Sigma-Tau Recent Developments
Table 76. Ipsen (Onivyde) Company Information
Table 77. Ipsen (Onivyde) Description and Business Overview
Table 78. Ipsen (Onivyde) Liposome Drug Delivery Product
Table 79. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 80. Ipsen (Onivyde) Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 81. Ipsen (Onivyde) Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 82. Ipsen (Onivyde) Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 83. Ipsen (Onivyde) Recent Developments
Table 84. CSPC Company Information
Table 85. CSPC Description and Business Overview
Table 86. CSPC Liposome Drug Delivery Product
Table 87. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 88. CSPC Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 89. CSPC Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 90. CSPC Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 91. CSPC Recent Developments
Table 92. Teva Pharmaceutical Company Information
Table 93. Teva Pharmaceutical Description and Business Overview
Table 94. Teva Pharmaceutical Liposome Drug Delivery Product
Table 95. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 96. Teva Pharmaceutical Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 97. Teva Pharmaceutical Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 98. Teva Pharmaceutical Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 99. Teva Pharmaceutical Recent Developments
Table 100. Novartis Company Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Liposome Drug Delivery Product
Table 103. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 104. Novartis Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 105. Novartis Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 106. Novartis Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 107. Novartis Recent Developments
Table 108. Fudan-Zhangjiang Company Information
Table 109. Fudan-Zhangjiang Description and Business Overview
Table 110. Fudan-Zhangjiang Liposome Drug Delivery Product
Table 111. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 112. Fudan-Zhangjiang Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 113. Fudan-Zhangjiang Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 114. Fudan-Zhangjiang Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 115. Fudan-Zhangjiang Recent Developments
Table 116. North America Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
Table 117. North America Liposome Drug Delivery Sales by Country (2026-2031) & (K Vial)
Table 118. North America Liposome Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 119. North America Liposome Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 120. North America Liposome Drug Delivery Sales by Type (2020-2025) & (K Vial)
Table 121. North America Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 122. Asia-Pacific Liposome Drug Delivery Sales by Region (2020-2025) & (K Vial)
Table 123. Asia-Pacific Liposome Drug Delivery Sales by Region (2026-2031) & (K Vial)
Table 124. Asia-Pacific Liposome Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
Table 125. Asia-Pacific Liposome Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
Table 126. Asia-Pacific Liposome Drug Delivery Sales by Type (2020-2025) & (K Vial)
Table 127. Asia-Pacific Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 128. Europe Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
Table 129. Europe Liposome Drug Delivery Sales by Country (2026-2031) & (K Vial)
Table 130. Europe Liposome Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 131. Europe Liposome Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 132. Europe Liposome Drug Delivery Sales by Type (2020-2025) & (K Vial)
Table 133. Europe Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 134. Latin America Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
Table 135. Latin America Liposome Drug Delivery Sales by Country (2026-2031) & (K Vial)
Table 136. Latin America Liposome Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 137. Latin America Liposome Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 138. Latin America Liposome Drug Delivery Sales by Type (2020-2025) & (K Vial)
Table 139. Latin America Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 140. Middle East and Africa Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
Table 141. Middle East and Africa Liposome Drug Delivery Sales by Country (2026-2031) & (K Vial)
Table 142. Middle East and Africa Liposome Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 143. Middle East and Africa Liposome Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 144. Middle East and Africa Liposome Drug Delivery Sales by Type (2020-2025) & (K Vial)
Table 145. Middle East and Africa Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 146. Liposome Drug Delivery Key Raw Materials, Industry Status and Trend
Table 147. Liposome Drug Delivery Key Raw Materials and Upstream Suppliers
Table 148. Liposome Drug Delivery Clients Status and Trend
Table 149. Liposome Drug Delivery Typical Clients
Table 150. Liposome Drug Delivery Distributors
Table 151. Liposome Drug Delivery Market Trends
Table 152. Liposome Drug Delivery Market Drivers
Table 153. Liposome Drug Delivery Market Challenges
Table 154. Liposome Drug Delivery Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 158. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Liposome Drug Delivery Product Picture
Figure 2. Global Liposome Drug Delivery Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Liposome Drug Delivery Sales Market Share by Type in 2024 & 2031
Figure 4. Liposomal Doxorubicin Product Picture
Figure 5. Liposomal Amphoteracin B Product Picture
Figure 6. Liposomal Paclitaxel Product Picture
Figure 7. Others Product Picture
Figure 8. Global Liposome Drug Delivery Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Liposome Drug Delivery Sales Market Share by Application in 2024 & 2031
Figure 10. Fungal Infection Therapy
Figure 11. Cancer & Tumor Therapy
Figure 12. Others
Figure 13. Liposome Drug Delivery Report Years Considered
Figure 14. Global Liposome Drug Delivery Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Liposome Drug Delivery Market Size 2020-2031 (US$ Million)
Figure 16. Global Liposome Drug Delivery Sales 2020-2031 (K Vial)
Figure 17. Global Liposome Drug Delivery Sales Market Share Forecast by Region (2020-2031)
Figure 18. Global Liposome Drug Delivery Revenue Market Share by Region (2020-2031)
Figure 19. Global Liposome Drug Delivery Sales Market Share Forecast by Type (2020-2031)
Figure 20. Global Liposome Drug Delivery Revenue Market Share Forecast by Type (2020-2031)
Figure 21. Liposome Drug Delivery Average Selling Price (ASP) by Type (2020-2025) & (USD/Vial)
Figure 22. Global Liposome Drug Delivery Sales Market Share Forecast by Application (2020-2031)
Figure 23. Global Liposome Drug Delivery Revenue Market Share Forecast by Application (2020-2031)
Figure 24. Liposome Drug Delivery Average Selling Price (ASP) by Application (2020-2025) & (USD/Vial)
Figure 25. Liposomal Doxorubicin of Liposome Drug Delivery Revenue Market Share by Application, 2024 VS 2031
Figure 26. Liposomal Amphoteracin B of Liposome Drug Delivery Revenue Market Share by Application, 2024 VS 2031
Figure 27. Liposomal Paclitaxel of Liposome Drug Delivery Revenue Market Share by Application, 2024 VS 2031
Figure 28. Others of Liposome Drug Delivery Revenue Market Share by Application, 2024 VS 2031
Figure 29. Global Liposome Drug Delivery Sales Share by Manufacturer in 2024
Figure 30. Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 31. Liposomal Doxorubicin Market Sales Proportion by Manufacturer in 2024
Figure 32. Liposomal Amphoteracin B Market Sales Proportion by Manufacturer in 2024
Figure 33. Liposomal Paclitaxel Market Sales Proportion by Manufacturer in 2024
Figure 34. Others Market Sales Proportion by Manufacturer in 2024
Figure 35. North America Liposome Drug Delivery Revenue 2020-2031 (US$ Million)
Figure 36. North America Liposome Drug Delivery Sales Market Share by Type (2020-2025)
Figure 37. North America Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 38. Asia-Pacific Liposome Drug Delivery Revenue 2020-2031 (US$ Million)
Figure 39. Asia-Pacific Liposome Drug Delivery Sales Market Share by Region (2020-2031)
Figure 40. Asia-Pacific Liposome Drug Delivery Revenue Market Share by Region (2020-2031)
Figure 41. Asia-Pacific Liposome Drug Delivery Sales Market Share by Type (2020-2025)
Figure 42. Asia-Pacific Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 43. Europe Liposome Drug Delivery Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Europe Liposome Drug Delivery Sales Market Share by Country (2020-2031)
Figure 45. Europe Liposome Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 46. Europe Liposome Drug Delivery Sales Market Share by Type (2020-2025)
Figure 47. Europe Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 48. Latin America Liposome Drug Delivery Revenue Growth Rate 2020-2031 (US$ Million)
Figure 49. Latin America Liposome Drug Delivery Sales Market Share by Country (2020-2031)
Figure 50. Latin America Liposome Drug Delivery Revenue Market Share by Country (2020-2025)
Figure 51. Latin America Liposome Drug Delivery Sales Market Share by Type (2020-2025)
Figure 52. Latin America Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 53. Middle East and Africa Liposome Drug Delivery Revenue Growth Rate 2020-2031 (US$ Million)
Figure 54. Middle East and Africa Liposome Drug Delivery Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Liposome Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Liposome Drug Delivery Sales Market Share by Type (2020-2025)
Figure 57. Middle East and Africa Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 58. Liposome Drug Delivery Supply Chain (Upstream and Downstream Market)
Figure 59. Global Production Market Share of Liposome Drug Delivery Raw Materials by Region in 2024
Figure 60. Liposome Drug Delivery Distribution Channels
Figure 61. Global Liposome Drug Delivery Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 62. Global Liposome Drug Delivery Percentage 2020-2031: Online Sales VS Offline Sales
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Liposome Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Liposome Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Liposome Drug Delivery Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Liposome Drug Delivery Sales by Region (2020-2025) & (K Vial)
Table 5. Global Liposome Drug Delivery Sales Forecast by Region (2026-2031) & (K Vial)
Table 6. Global Liposome Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Liposome Drug Delivery Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Liposome Drug Delivery Sales Volume by Type (2020-2025) & (K Vial)
Table 9. Global Liposome Drug Delivery Sales Volume by Type (2026-2031) & (K Vial)
Table 10. Global Liposome Drug Delivery Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Liposome Drug Delivery Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Liposome Drug Delivery Sales Volume by Application (2020-2025) & (K Vial)
Table 13. Global Liposome Drug Delivery Sales Volume by Application (2026-2031) & (K Vial)
Table 14. Global Liposome Drug Delivery Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Liposome Drug Delivery Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Liposome Drug Delivery Sales by Manufacturer (2020-2025) & (K Vial)
Table 17. Global Liposome Drug Delivery Sales Share by Manufacturer (2020-2025)
Table 18. Liposome Drug Delivery Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Liposome Drug Delivery Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Liposome Drug Delivery Price (2020-2025) & (USD/Vial)
Table 21. Ranking of Global Top Liposome Drug Delivery Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Liposome Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Liposome Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Drug Delivery as of 2024)
Table 24. Liposome Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Liposome Drug Delivery Market
Table 26. Manufacturers Liposome Drug Delivery Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Gilead Sciences Company Information
Table 29. Gilead Sciences Description and Business Overview
Table 30. Gilead Sciences Liposome Drug Delivery Product
Table 31. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 32. Gilead Sciences Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 33. Gilead Sciences Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 34. Gilead Sciences Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 35. Gilead Sciences Recent Developments
Table 36. Pacira Company Information
Table 37. Pacira Description and Business Overview
Table 38. Pacira Liposome Drug Delivery Product
Table 39. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 40. Pacira Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 41. Pacira Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 42. Pacira Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 43. Pacira Recent Developments
Table 44. Sun Pharmaceutical Company Information
Table 45. Sun Pharmaceutical Description and Business Overview
Table 46. Sun Pharmaceutical Liposome Drug Delivery Product
Table 47. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 48. Sun Pharmaceutical Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 49. Sun Pharmaceutical Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 50. Sun Pharmaceutical Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 51. Sun Pharmaceutical Recent Developments
Table 52. Johnson & Johnson Company Information
Table 53. Johnson & Johnson Description and Business Overview
Table 54. Johnson & Johnson Liposome Drug Delivery Product
Table 55. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 56. Johnson & Johnson Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 57. Johnson & Johnson Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 58. Johnson & Johnson Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 59. Johnson & Johnson Recent Developments
Table 60. Luye Pharma Company Information
Table 61. Luye Pharma Description and Business Overview
Table 62. Luye Pharma Liposome Drug Delivery Product
Table 63. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 64. Luye Pharma Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 65. Luye Pharma Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 66. Luye Pharma Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 67. Luye Pharma Recent Developments
Table 68. Sigma-Tau Company Information
Table 69. Sigma-Tau Description and Business Overview
Table 70. Sigma-Tau Liposome Drug Delivery Product
Table 71. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 72. Sigma-Tau Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 73. Sigma-Tau Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 74. Sigma-Tau Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 75. Sigma-Tau Recent Developments
Table 76. Ipsen (Onivyde) Company Information
Table 77. Ipsen (Onivyde) Description and Business Overview
Table 78. Ipsen (Onivyde) Liposome Drug Delivery Product
Table 79. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 80. Ipsen (Onivyde) Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 81. Ipsen (Onivyde) Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 82. Ipsen (Onivyde) Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 83. Ipsen (Onivyde) Recent Developments
Table 84. CSPC Company Information
Table 85. CSPC Description and Business Overview
Table 86. CSPC Liposome Drug Delivery Product
Table 87. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 88. CSPC Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 89. CSPC Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 90. CSPC Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 91. CSPC Recent Developments
Table 92. Teva Pharmaceutical Company Information
Table 93. Teva Pharmaceutical Description and Business Overview
Table 94. Teva Pharmaceutical Liposome Drug Delivery Product
Table 95. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 96. Teva Pharmaceutical Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 97. Teva Pharmaceutical Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 98. Teva Pharmaceutical Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 99. Teva Pharmaceutical Recent Developments
Table 100. Novartis Company Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Liposome Drug Delivery Product
Table 103. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 104. Novartis Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 105. Novartis Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 106. Novartis Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 107. Novartis Recent Developments
Table 108. Fudan-Zhangjiang Company Information
Table 109. Fudan-Zhangjiang Description and Business Overview
Table 110. Fudan-Zhangjiang Liposome Drug Delivery Product
Table 111. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 112. Fudan-Zhangjiang Sales Proportion of Liposome Drug Delivery by Product in 2024
Table 113. Fudan-Zhangjiang Sales Proportion of Liposome Drug Delivery by Application in 2024
Table 114. Fudan-Zhangjiang Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
Table 115. Fudan-Zhangjiang Recent Developments
Table 116. North America Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
Table 117. North America Liposome Drug Delivery Sales by Country (2026-2031) & (K Vial)
Table 118. North America Liposome Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 119. North America Liposome Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 120. North America Liposome Drug Delivery Sales by Type (2020-2025) & (K Vial)
Table 121. North America Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 122. Asia-Pacific Liposome Drug Delivery Sales by Region (2020-2025) & (K Vial)
Table 123. Asia-Pacific Liposome Drug Delivery Sales by Region (2026-2031) & (K Vial)
Table 124. Asia-Pacific Liposome Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
Table 125. Asia-Pacific Liposome Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
Table 126. Asia-Pacific Liposome Drug Delivery Sales by Type (2020-2025) & (K Vial)
Table 127. Asia-Pacific Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 128. Europe Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
Table 129. Europe Liposome Drug Delivery Sales by Country (2026-2031) & (K Vial)
Table 130. Europe Liposome Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 131. Europe Liposome Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 132. Europe Liposome Drug Delivery Sales by Type (2020-2025) & (K Vial)
Table 133. Europe Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 134. Latin America Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
Table 135. Latin America Liposome Drug Delivery Sales by Country (2026-2031) & (K Vial)
Table 136. Latin America Liposome Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 137. Latin America Liposome Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 138. Latin America Liposome Drug Delivery Sales by Type (2020-2025) & (K Vial)
Table 139. Latin America Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 140. Middle East and Africa Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
Table 141. Middle East and Africa Liposome Drug Delivery Sales by Country (2026-2031) & (K Vial)
Table 142. Middle East and Africa Liposome Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 143. Middle East and Africa Liposome Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 144. Middle East and Africa Liposome Drug Delivery Sales by Type (2020-2025) & (K Vial)
Table 145. Middle East and Africa Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 146. Liposome Drug Delivery Key Raw Materials, Industry Status and Trend
Table 147. Liposome Drug Delivery Key Raw Materials and Upstream Suppliers
Table 148. Liposome Drug Delivery Clients Status and Trend
Table 149. Liposome Drug Delivery Typical Clients
Table 150. Liposome Drug Delivery Distributors
Table 151. Liposome Drug Delivery Market Trends
Table 152. Liposome Drug Delivery Market Drivers
Table 153. Liposome Drug Delivery Market Challenges
Table 154. Liposome Drug Delivery Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 158. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Liposome Drug Delivery Product Picture
Figure 2. Global Liposome Drug Delivery Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Liposome Drug Delivery Sales Market Share by Type in 2024 & 2031
Figure 4. Liposomal Doxorubicin Product Picture
Figure 5. Liposomal Amphoteracin B Product Picture
Figure 6. Liposomal Paclitaxel Product Picture
Figure 7. Others Product Picture
Figure 8. Global Liposome Drug Delivery Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Liposome Drug Delivery Sales Market Share by Application in 2024 & 2031
Figure 10. Fungal Infection Therapy
Figure 11. Cancer & Tumor Therapy
Figure 12. Others
Figure 13. Liposome Drug Delivery Report Years Considered
Figure 14. Global Liposome Drug Delivery Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Liposome Drug Delivery Market Size 2020-2031 (US$ Million)
Figure 16. Global Liposome Drug Delivery Sales 2020-2031 (K Vial)
Figure 17. Global Liposome Drug Delivery Sales Market Share Forecast by Region (2020-2031)
Figure 18. Global Liposome Drug Delivery Revenue Market Share by Region (2020-2031)
Figure 19. Global Liposome Drug Delivery Sales Market Share Forecast by Type (2020-2031)
Figure 20. Global Liposome Drug Delivery Revenue Market Share Forecast by Type (2020-2031)
Figure 21. Liposome Drug Delivery Average Selling Price (ASP) by Type (2020-2025) & (USD/Vial)
Figure 22. Global Liposome Drug Delivery Sales Market Share Forecast by Application (2020-2031)
Figure 23. Global Liposome Drug Delivery Revenue Market Share Forecast by Application (2020-2031)
Figure 24. Liposome Drug Delivery Average Selling Price (ASP) by Application (2020-2025) & (USD/Vial)
Figure 25. Liposomal Doxorubicin of Liposome Drug Delivery Revenue Market Share by Application, 2024 VS 2031
Figure 26. Liposomal Amphoteracin B of Liposome Drug Delivery Revenue Market Share by Application, 2024 VS 2031
Figure 27. Liposomal Paclitaxel of Liposome Drug Delivery Revenue Market Share by Application, 2024 VS 2031
Figure 28. Others of Liposome Drug Delivery Revenue Market Share by Application, 2024 VS 2031
Figure 29. Global Liposome Drug Delivery Sales Share by Manufacturer in 2024
Figure 30. Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 31. Liposomal Doxorubicin Market Sales Proportion by Manufacturer in 2024
Figure 32. Liposomal Amphoteracin B Market Sales Proportion by Manufacturer in 2024
Figure 33. Liposomal Paclitaxel Market Sales Proportion by Manufacturer in 2024
Figure 34. Others Market Sales Proportion by Manufacturer in 2024
Figure 35. North America Liposome Drug Delivery Revenue 2020-2031 (US$ Million)
Figure 36. North America Liposome Drug Delivery Sales Market Share by Type (2020-2025)
Figure 37. North America Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 38. Asia-Pacific Liposome Drug Delivery Revenue 2020-2031 (US$ Million)
Figure 39. Asia-Pacific Liposome Drug Delivery Sales Market Share by Region (2020-2031)
Figure 40. Asia-Pacific Liposome Drug Delivery Revenue Market Share by Region (2020-2031)
Figure 41. Asia-Pacific Liposome Drug Delivery Sales Market Share by Type (2020-2025)
Figure 42. Asia-Pacific Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 43. Europe Liposome Drug Delivery Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Europe Liposome Drug Delivery Sales Market Share by Country (2020-2031)
Figure 45. Europe Liposome Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 46. Europe Liposome Drug Delivery Sales Market Share by Type (2020-2025)
Figure 47. Europe Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 48. Latin America Liposome Drug Delivery Revenue Growth Rate 2020-2031 (US$ Million)
Figure 49. Latin America Liposome Drug Delivery Sales Market Share by Country (2020-2031)
Figure 50. Latin America Liposome Drug Delivery Revenue Market Share by Country (2020-2025)
Figure 51. Latin America Liposome Drug Delivery Sales Market Share by Type (2020-2025)
Figure 52. Latin America Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 53. Middle East and Africa Liposome Drug Delivery Revenue Growth Rate 2020-2031 (US$ Million)
Figure 54. Middle East and Africa Liposome Drug Delivery Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Liposome Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Liposome Drug Delivery Sales Market Share by Type (2020-2025)
Figure 57. Middle East and Africa Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 58. Liposome Drug Delivery Supply Chain (Upstream and Downstream Market)
Figure 59. Global Production Market Share of Liposome Drug Delivery Raw Materials by Region in 2024
Figure 60. Liposome Drug Delivery Distribution Channels
Figure 61. Global Liposome Drug Delivery Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 62. Global Liposome Drug Delivery Percentage 2020-2031: Online Sales VS Offline Sales
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232